Goal-Directed Fluid Therapy (GDFT)

DRUG3 trials

Sponsors

RenJi Hospital, Cukurova University, Indonesia University

Conditions

Delayed Graft FunctionElective Major Abdominal SurgeryEnd Stage Renal DiseaseEnhanced Recovery After AnesthesiaKidney TransplantationLung CancerThoracic AnesthesiaThoracoscopic Lobectomy

Unknown Phase

Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations

RecruitingNCT06367205

RenJi HospitalDelayed Graft Function, End Stage Renal Disease, Kidney Transplantation

Start: 2024-03-01End: 2026-06-30Target: 380Updated: 2024-04-16

Goal-Directed Fluid Therapy for Thoracoscopic Lobectomy

CompletedNCT07050979

Cukurova UniversityThoracoscopic Lobectomy, Thoracic Anesthesia, Enhanced Recovery After Anesthesia +1

Start: 2024-06-01End: 2025-01-25Updated: 2025-07-03

Effectiveness of Goal-Directed Fluid Therapy Guided by Cardiac Index Versus Central Venous Pressure in Major Abdominal Surgery Patients in the ICU.

RecruitingNCT07303855

Indonesia UniversityElective Major Abdominal Surgery

Start: 2025-12-01End: 2026-02-28Target: 60Updated: 2025-12-29

Related Papers

The effects of norepinephrine infusion combined with goal-directed fluid therapy on delayed graft function in patients undergoing kidney transplantations: study protocol for a multicenter randomized controlled trial

Trials2026-08-29